Sensei Biotherapeutics Q1 2024 GAAP EPS $(0.32) Misses $(0.29) Estimate
Portfolio Pulse from Benzinga Newsdesk
Sensei Biotherapeutics reported a Q1 2024 GAAP EPS of $(0.32), missing the estimated $(0.29) by analysts.
May 09, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Sensei Biotherapeutics' Q1 2024 earnings missed analyst estimates, reporting a GAAP EPS of $(0.32) against the expected $(0.29).
Earnings misses typically lead to negative investor sentiment in the short term, potentially causing a decrease in stock price as expectations are not met.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100